Synthesis and evaluation of new quinoline-piperazine/pyrrolidine compounds against leishmaniasis
Nov. 24, 2023
Central Drug Research Institute investigators have synthesized novel compounds conjugating the quinoline moiety with a piperazine/pyrrolidine scaffold through a molecular hybridization approach and investigated their antileishmanial activity.